包括Zurcher Kantonalbank在内的投资公司增加了Bio-Rad的股份,提高了其股票价值。 Investment firms, including Zurcher Kantonalbank, increased stakes in Bio-Rad, boosting its stock value.

Zurcher Kantonal银行在第四季度将生物射线实验室的股份增加了67.2%,现在拥有价值348万美元的10 588股股票。 Zurcher Kantonalbank increased its stake in Bio-Rad Laboratories by 67.2% in the fourth quarter, now owning 10,588 shares worth $3.48 million. Bio-Rad,一家医学研究公司,报告EPS为2.90美元,殴打分析师估计数为0.04美元。 Bio-Rad, a medical research company, reported an EPS of $2.90, beating analyst estimates by $0.04. 该公司的市场上限为715亿美元。 The company has a market cap of $7.15 billion. 诸如Veration Fund Management 和Proficio Capital Partners等投资公司也增加了其在Bio-Rad的持有量,这表明投资者的兴趣日益增加。 Investment firms like Verition Fund Management and Proficio Capital Partners have also increased their holdings in Bio-Rad, indicating growing investor interest.